Events Search and Views Navigation
April 2021
Redeye Orphan Drugs
Abliva will participate at Redeye's seminar on ‘Drug development in orphan indications.’ CEO Ellen Donnelly will be presenting the company during the event. Follow link below for further details and live webcast.
Find out more »